SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050880
Filing Date
2020-11-05
Accepted
2020-11-05 07:46:08
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20200930.htm   iXBRL 10-Q 2203626
2 EX-10.1 kura-ex101_12.htm EX-10.1 114232
3 EX-10.2 kura-ex102_187.htm EX-10.2 45399
4 EX-31.1 kura-ex311_9.htm EX-31.1 17446
5 EX-31.2 kura-ex312_7.htm EX-31.2 17256
6 EX-32.1 kura-ex321_6.htm EX-32.1 9552
  Complete submission text file 0001564590-20-050880.txt   6600854

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20200930.xsd EX-101.SCH 38804
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20200930_cal.xml EX-101.CAL 43339
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20200930_def.xml EX-101.DEF 101473
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20200930_lab.xml EX-101.LAB 287090
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20200930_pre.xml EX-101.PRE 206380
12 EXTRACTED XBRL INSTANCE DOCUMENT kura-10q_20200930_htm.xml XML 1121064
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 201288734
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences